FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029596738> ?p ?o ?g. }

• W2029596738 endingPage "769" @default.
• W2029596738 startingPage "762" @default.
• W2029596738 abstract "Summary In the initial treatment of venous thromboembolism (VTE) fondaparinux, a pentasaccharide, is a good alternative to heparin. Whether this is also true for cancer patients is unknown. We performed two post-hoc analyses of two randomized studies to compare efficacy, safety and overall survival of fondaparinux to standard initial (low-molecular-weight) heparin (LMWH) treatment in cancer patients with venous thromboembolism. Two hundred thirty-seven cancer patients with deep venous thrombosis (DVT) were initially treated with fondaparinux or enoxaparin. Two hundred forty cancer patients with pulmonary embolism (PE) received fondaparinux or unfractionated heparin. The initial treatment was followed by vitamin K antagonists. In DVT patients, the three-month recurrence rate was 5.4% in the enoxaparin recipients compared to 12.7% in those treated with fondaparinux [absolute difference 7.3%, 95% CI 0.1, 14.5]. A recurrence was observed in 8.9% of the PE patients treated with fondaparinux compared to 17.2% in the unfractionated heparin recipients [absolute difference –8.3, 95% CI –16.7, 0.1]. In both studies no difference in bleeding and overall survival was observed. Regarding overall survival and bleeding fondaparinux is comparable to enoxaparin and unfractionated heparin in cancer patients. No significant differences in recurrent VTE were observed when comparing fondaparinux with unfractionated or LMWH. Because of study limitations these results should be considered hypothesis-generating." @default.
• W2029596738 created "2016-06-24" @default.
• W2029596738 creator A5006968262 @default.
• W2029596738 creator A5025282606 @default.
• W2029596738 creator A5029283176 @default.
• W2029596738 creator A5039204383 @default.
• W2029596738 creator A5042290277 @default.
• W2029596738 creator A5071135543 @default.
• W2029596738 creator A5077272475 @default.
• W2029596738 creator A5086036714 @default.
• W2029596738 creator A5088320381 @default.
• W2029596738 date "2009-01-01" @default.
• W2029596738 modified "2023-10-18" @default.
• W2029596738 title "Treatment of venous thromboembolism in patients with cancer: Subgroup analysis of the Matisse clinical trials" @default.
• W2029596738 cites W1589216059 @default.
• W2029596738 cites W1955610473 @default.
• W2029596738 cites W1984833612 @default.
• W2029596738 cites W1990154448 @default.
• W2029596738 cites W1991879020 @default.
• W2029596738 cites W1992661527 @default.
• W2029596738 cites W2000130043 @default.
• W2029596738 cites W2010481138 @default.
• W2029596738 cites W2015962018 @default.
• W2029596738 cites W2039337035 @default.
• W2029596738 cites W2053896427 @default.
• W2029596738 cites W2054169479 @default.
• W2029596738 cites W2054324054 @default.
• W2029596738 cites W2070112905 @default.
• W2029596738 cites W2115019673 @default.
• W2029596738 cites W2132300233 @default.
• W2029596738 cites W2134908914 @default.
• W2029596738 cites W2138438886 @default.
• W2029596738 cites W2159553511 @default.
• W2029596738 cites W2166945512 @default.
• W2029596738 cites W3021525014 @default.
• W2029596738 cites W2084186985 @default.
• W2029596738 doi "https://doi.org/10.1160/th08-09-0563" @default.
• W2029596738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19350123" @default.
• W2029596738 hasPublicationYear "2009" @default.
• W2029596738 type Work @default.
• W2029596738 sameAs 2029596738 @default.
• W2029596738 citedByCount "91" @default.
• W2029596738 countsByYear W20295967382012 @default.
• W2029596738 countsByYear W20295967382013 @default.
• W2029596738 countsByYear W20295967382014 @default.
• W2029596738 countsByYear W20295967382015 @default.
• W2029596738 countsByYear W20295967382016 @default.
• W2029596738 countsByYear W20295967382017 @default.
• W2029596738 countsByYear W20295967382018 @default.
• W2029596738 countsByYear W20295967382019 @default.
• W2029596738 countsByYear W20295967382020 @default.
• W2029596738 countsByYear W20295967382021 @default.
• W2029596738 countsByYear W20295967382022 @default.
• W2029596738 countsByYear W20295967382023 @default.
• W2029596738 crossrefType "journal-article" @default.
• W2029596738 hasAuthorship W2029596738A5006968262 @default.
• W2029596738 hasAuthorship W2029596738A5025282606 @default.
• W2029596738 hasAuthorship W2029596738A5029283176 @default.
• W2029596738 hasAuthorship W2029596738A5039204383 @default.
• W2029596738 hasAuthorship W2029596738A5042290277 @default.
• W2029596738 hasAuthorship W2029596738A5071135543 @default.
• W2029596738 hasAuthorship W2029596738A5077272475 @default.
• W2029596738 hasAuthorship W2029596738A5086036714 @default.
• W2029596738 hasAuthorship W2029596738A5088320381 @default.
• W2029596738 hasConcept C121608353 @default.
• W2029596738 hasConcept C126322002 @default.
• W2029596738 hasConcept C141071460 @default.
• W2029596738 hasConcept C2776265017 @default.
• W2029596738 hasConcept C2776877702 @default.
• W2029596738 hasConcept C2776884760 @default.
• W2029596738 hasConcept C2777557582 @default.
• W2029596738 hasConcept C2780011451 @default.
• W2029596738 hasConcept C2780868729 @default.
• W2029596738 hasConcept C2991741193 @default.
• W2029596738 hasConcept C42219234 @default.
• W2029596738 hasConcept C71924100 @default.
• W2029596738 hasConceptScore W2029596738C121608353 @default.
• W2029596738 hasConceptScore W2029596738C126322002 @default.
• W2029596738 hasConceptScore W2029596738C141071460 @default.
• W2029596738 hasConceptScore W2029596738C2776265017 @default.
• W2029596738 hasConceptScore W2029596738C2776877702 @default.
• W2029596738 hasConceptScore W2029596738C2776884760 @default.
• W2029596738 hasConceptScore W2029596738C2777557582 @default.
• W2029596738 hasConceptScore W2029596738C2780011451 @default.
• W2029596738 hasConceptScore W2029596738C2780868729 @default.
• W2029596738 hasConceptScore W2029596738C2991741193 @default.
• W2029596738 hasConceptScore W2029596738C42219234 @default.
• W2029596738 hasConceptScore W2029596738C71924100 @default.
• W2029596738 hasIssue "04" @default.
• W2029596738 hasLocation W20295967381 @default.
• W2029596738 hasLocation W20295967382 @default.
• W2029596738 hasOpenAccess W2029596738 @default.
• W2029596738 hasPrimaryLocation W20295967381 @default.
• W2029596738 hasRelatedWork W1553713421 @default.
• W2029596738 hasRelatedWork W1990111999 @default.
• W2029596738 hasRelatedWork W220073818 @default.
• W2029596738 hasRelatedWork W2402226324 @default.
• W2029596738 hasRelatedWork W2416822451 @default.

• next